TribLIVE

| Business

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J&J wins U.S. approval for TB tablet

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

JNJ $70.10 +$0.62

at close on MONDAY

By Anna Edney C.2012 Bloomberg News
Monday, Dec. 31, 2012, 10:30 p.m.
 

Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.

The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.

While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Business Headlines

  1. Popularity of emerging markets wanes
  2. Steelworkers union says ATI talks to resume
  3. Trib 30 takes bigger hit than Dow in August
  4. Sniffer lets PixController detect methane gas leaks
  5. ModCloth gets physical
  6. Tubman, Anthony win support for redesigned $10 bill
  7. Gasoline prices down nearly a dime in Pittsburgh area
  8. August stock markets marked by fierce, deep selling
  9. Rankings: CEO pay 200 times median
  10. S.W. Randall Toyes & Giftes of Pittsburgh’s owner finds joy in toys
  11. Shale gas violations down as DEP steps up inspections